Posts by David S. Friedman, MD, PhD, MPH
-
Van Herick Grading Not a Useful Screening Tool on Population Level
David S. Friedman, MD, PhD, MPH, and colleagues found that van Herick grading of limbal anterior chamber depth may be useful for identifying iridotrabecular contact, but a relatively high false positive rate limits its usefulness for community-based screening for primary angle closure.
-
Using Technology to Assess Patient-recorded Outcomes in Glaucoma Treatment
David S. Friedman, MD, PhD, MPH, a clinician scientist and director of the Glaucoma Service at Mass Eye and Ear, discusses a pilot program to assess patient-reported outcomes for glaucoma treatment.
-
Using Artificial Intelligence to Diagnose Glaucoma
David S. Friedman, MD, PhD, MPH, a clinician-scientist and director of the Glaucoma Service in the Department of Ophthalmology, discusses the implementation of artificial intelligence in the detection of glaucoma in screening with photographs.
Biography
Dr. Friedman is the Director of the Glaucoma Service, who specializes in treating all forms of glaucoma except for pediatric patients. He has pursued excellence in clinical care, research, and education, and is considered a leader in all three fields. As a clinician he has consistently been elected a “Best Doctor” and frequently is asked to lecture both domestically and internationally on glaucoma care. He is world renowned for the treatment of angle closure glaucoma. He performs a wide range of glaucoma procedures as well as cataract surgery.
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
